Real-world efficacy and safety of cabozantinib following immune checkpoint inhibitor failure in Japanese patients with advanced renal cell carcinoma

Abstract Background Real-world data of cabozantinib after failure of immune checkpoint inhibitors for advanced renal cell carcinoma in Japanese population are limited. Additionally, prognostic factors of cabozantinib in this setting are still unknown. Methods We retrospectively evaluated data of 56...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Japanese journal of clinical oncology 2023-10, Vol.53 (10), p.977-983
Hauptverfasser:	Ishihara, Hiroki, Nemoto, Yuki, Tachibana, Hidekazu, Fukuda, Hironori, Yoshida, Kazuhiko, Kobayashi, Hirohito, Iizuka, Junpei, Hashimoto, Yasunobu, Kondo, Tsunenori, Takagi, Toshio
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!